AbbVie's sNDA accepted for priority review for Imbruvica in combination with Gazyva for previously untreated CLL

Oncofertility has been an overlooked standard of care—now states are taking action

Recently, a wave of new private insurance mandates have swept the nation making fertility preservation a covered benefit for people with cancer in 21 states plus Washington, DC.

November 26, 2025

Clinical

Oncofertility coverage mandates expand to 21 states and DC as political momentum builds
Gaps persist as patients face harrowing decisions and huge copays

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

November 21, 2025

Vol.51 No.43

By Claire Marie Porter and Sara Willa Ernst

Conversation with The Cancer Letter

Shane Jacobson talks about his to-do list for ACS
Boost research, forge closer ties with cancer centers, launch an all-out campaign for resources

Two months into his job as CEO of the American Cancer Society and American Cancer Society Cancer Action Network, Shane Jacobson is still in the drinking-water-from-the-firehose stage of the job.

November 21, 2025

Vol.51 No.43

Guest Editorial

My introduction to, and lessons learned from, Rick Pazdur

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.

November 21, 2025

Vol.51 No.43

By Mikkael A. Sekeres

Obituary

Montefiore Einstein Director Edward Chu dies of glioblastoma at 66

Edward Chu was an expert in pharmacology whose research improved therapies for colorectal cancer, leading to the identification of new treatment targets and driving scientific advances in the field.

November 21, 2025

Vol.51 No.43

By Roy S. Herbst, Mario Sznol, Vincent T. DeVita Jr., Robert L. Ferris, Nancy E. Davidson, Otis W. Brawley, Roy A. Jensen, Weijing Sun and Montefiore Einstein staff

Obituary

Arnold D. Kaluzny, longtime adviser to the NCI and health services researcher, dies at 87

Arnold Daniel “Arnie” Kaluzny, PhD, longtime adviser to NCI and an early pioneer and contributor to what is now known as health services research, died Oct. 29 at the age of 87.

November 21, 2025

Vol.51 No.43

By Donna M. O’Brien and Barnett Kramer

AbbVie’s sNDA accepted for priority review for Imbruvica in combination with Gazyva for previously untreated CLL

YOU MAY BE INTERESTED IN

Oncofertility has been an overlooked standard of care—now states are taking action

Oncofertility coverage mandates expand to 21 states and DC as political momentum builds
Gaps persist as patients face harrowing decisions and huge copays

Shane Jacobson talks about his to-do list for ACS
Boost research, forge closer ties with cancer centers, launch an all-out campaign for resources

My introduction to, and lessons learned from, Rick Pazdur

Montefiore Einstein Director Edward Chu dies of glioblastoma at 66

Arnold D. Kaluzny, longtime adviser to the NCI and health services researcher, dies at 87

Renew today!

Subscriber content

Never miss an issue!

Login

AbbVie’s sNDA accepted for priority review for Imbruvica in combination with Gazyva for previously untreated CLL

YOU MAY BE INTERESTED IN

Oncofertility has been an overlooked standard of care—now states are taking action

Oncofertility coverage mandates expand to 21 states and DC as political momentum buildsGaps persist as patients face harrowing decisions and huge copays

Shane Jacobson talks about his to-do list for ACSBoost research, forge closer ties with cancer centers, launch an all-out campaign for resources

My introduction to, and lessons learned from, Rick Pazdur

Montefiore Einstein Director Edward Chu dies of glioblastoma at 66

Arnold D. Kaluzny, longtime adviser to the NCI and health services researcher, dies at 87

Never miss an issue!

Login

Oncofertility coverage mandates expand to 21 states and DC as political momentum builds
Gaps persist as patients face harrowing decisions and huge copays

Shane Jacobson talks about his to-do list for ACS
Boost research, forge closer ties with cancer centers, launch an all-out campaign for resources